Maintenance fees coming due
25 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 13, 2026. Unpaid by Jun 14, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,673,951 | ANTI-PD1 Antibodies and Their Use as Therapeutics and Diagnostics In force Fee due Dec 13, 2026 Lapses if unpaid Jun 14, 2027 · Low confidence | Beone Medicines I GmbH | In force | Dec 13, 2026 | Jun 14, 2027 | Low confidence | |
| US 10,351,559 | Maleate Salts of a B-Raf Kinase Inhibitor, Crystalline Forms, Methods of Preparation, and Uses Therefore In force Fee due Jan 16, 2027 Lapses if unpaid Jul 16, 2027 · High confidence | Beone Medicines I GmbH | In force | Jan 16, 2027 | Jul 16, 2027 | High confidence | |
| US 11,701,357 | Treatment of B Cell Cancers Using a Combination Comprising BTK Inhibitors and Obinutuzumab In force Fee due Jan 18, 2027 Lapses if unpaid Jul 19, 2027 · High confidence | Beone Medicines I GmbH | In force | Jan 18, 2027 | Jul 19, 2027 | High confidence | |
| US 11,725,012 | IMIDAZO[1,5-a]PYRAZINE DERIVATIVES AS PI3K DELTA INHIBITORS In force Fee due Feb 15, 2027 Lapses if unpaid Aug 16, 2027 · High confidence | Beone Medicines I GmbH | In force | Feb 15, 2027 | Aug 16, 2027 | High confidence | |
| US 11,786,529 | Treatment of Indolent or Aggressive B-Cell Lymphomas Using a Combination Comprising BTK Inhibitors In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 · High confidence | Beone Medicines I GmbH | In force | Apr 17, 2027 | Oct 18, 2027 | High confidence | |
| US 11,786,531 | Methods of Treating B-Cell Proliferative Disorder In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 · High confidence | Beone Medicines I GmbH | In force | Apr 17, 2027 | Oct 18, 2027 | High confidence | |
| US 10,457,680 | Process for Preparing a Parp Inhibitor, Crystalline Forms, and Uses Thereof In force Fee due Apr 29, 2027 Lapses if unpaid Oct 29, 2027 · High confidence | Beone Medicines I GmbH | In force | Apr 29, 2027 | Oct 29, 2027 | High confidence | |
| US 11,814,389 | CRYSTALLINE FORM OF (S)-7-(1-Acryloylpiperidin-4-YL)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-Carboxamide, PREPARATION, AND USES THEREOF In force Fee due May 14, 2027 Lapses if unpaid Nov 15, 2027 · High confidence | Beone Medicines I GmbH | In force | May 14, 2027 | Nov 15, 2027 | High confidence | |
| US 10,501,467 | Fused Tetra or Penta-Cyclic Dihydrodiazepinocarbazolones as Parp Inhibitors In force Fee due Jun 10, 2027 Lapses if unpaid Dec 10, 2027 · High confidence | Beone Medicines I GmbH | In force | Jun 10, 2027 | Dec 10, 2027 | High confidence | |
| US 9,217,034 | ANTI-PD1 Antibodies and Their Use as Therapeutics and Diagnostics In force Fee due Jun 22, 2027 Lapses if unpaid Dec 22, 2027 · Medium confidence | Beone Medicines I GmbH | In force | Jun 22, 2027 | Dec 22, 2027 | Medium confidence | |
| 15 more maintenance fees coming due in the 12 months from Nov 21, 2026 · Pro | |||||||
10 of 25 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.